MENU
JAZZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Jazz Pharmaceuticals (JAZZ) Earnings Date & Reports

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology... Show more

A.I. Advisor
published Earnings

JAZZ is expected to report earnings to fall 26.97% to $4.82 per share on April 30

Jazz Pharmaceuticals JAZZ Stock Earnings Reports
Q1'25
Est.
$4.82
Q4'24
Beat
by $0.81
Q3'24
Beat
by $1.11
Q2'24
Beat
by $0.53
Q1'24
Missed
by $1.50
The last earnings report on February 25 showed earnings per share of $6.60, beating the estimate of $5.79. With 182.85K shares outstanding, the current market capitalization sits at 7.34B.
View a ticker or compare two or three
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Waterloo Road
Phone
+353 16347800
Employees
2800
Web
https://www.jazzpharmaceuticals.com